Cargando…

Geographic Distribution of HCV-GT3 Subtypes and Naturally Occurring Resistance Associated Substitutions

Background: Little is known about the frequency or geographic distributions of naturally occurring resistance-associated substitutions (RASs) in the nonstructural protein 5A (NS5A) domain of hepatitis-C virus (HCV) genotype-3 (GT-3) different subtypes. We investigated naturally occurring GT-3 RASs t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bagaglio, Sabrina, Messina, Emanuela, Hasson, Hamid, Galli, Andrea, Uberti-Foppa, Caterina, Morsica, Giulia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410151/ https://www.ncbi.nlm.nih.gov/pubmed/30754682 http://dx.doi.org/10.3390/v11020148

Ejemplares similares

Compartmentalization of Resistance-Associated Substitutions in HIV/HCV-Infected Patients: Possible Correlation with Infecting HCV Genotype
por: Morsica, Giulia, et al.
Publicado: (2021)

Natural polymorphisms in the resistance associated sites of HCV-G1 NS5B domain and correlation with geographic origin of HCV isolates
por: Bagaglio, Sabrina, et al.
Publicado: (2018)

A Prospective Italian Study on Baseline NS3 and NS5A Resistance to Direct-Acting Antivirals in a Real-World Setting of HIV-1/HCV Coinfected Patients and Association with Treatment Outcome
por: Bagaglio, Sabrina, et al.
Publicado: (2020)

Risk of HIV viral rebound in HIV infected patients on direct acting antivirals (DAAs) treatment for HCV
por: Morsica, Giulia, et al.
Publicado: (2022)

Dynamic of Mixed HCV Infection in Plasma and PBMC of HIV/HCV Patients Under Treatment With Peg-IFN/Ribavirin
por: Bagaglio, Sabrina, et al.
Publicado: (2015)

Levels of Alpha-Fetoprotein and Association with Mortality in Hepatocellular Carcinoma of HIV-1-Infected Patients
por: Morsica, Giulia, et al.
Publicado: (2022)

Frequency of Natural Resistance within NS5a Replication Complex Domain in Hepatitis C Genotypes 1a, 1b: Possible Implication of Subtype-Specific Resistance Selection in Multiple Direct Acting Antivirals Drugs Combination Treatment
por: Bagaglio, Sabrina, et al.
Publicado: (2016)

Molecular epidemiology of HIV-1 infection in immigrant population in northern Italy
por: Sagnelli, Caterina, et al.
Publicado: (2020)

Virological pattern of hepatitis B infection in an HIV-positive man with fatal fulminant hepatitis B: a case report
por: Bagaglio, Sabrina, et al.
Publicado: (2009)

Survival in People Living with HIV with or without Recurrence of Hepatocellular Carcinoma after Invasive Therapy
por: Bertoni, Costanza, et al.
Publicado: (2023)

Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols
por: Caputo, Valeria, et al.
Publicado: (2020)

Modelling the impact of protein-kinase R allelic variant on HIV biomarkers trajectories by means of latent class mixed models
por: Brombin, Chiara, et al.
Publicado: (2022)

Immune response to hepatitis B vaccination in HIV-positive individuals with isolated antibodies against hepatitis B core antigen: Results of a prospective Italian study
por: Morsica, Giulia, et al.
Publicado: (2017)

Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients
por: Sagnelli, Caterina, et al.
Publicado: (2017)

Emergence and Persistence of Resistance-Associated Substitutions in HCV GT3 Patients Failing Direct-Acting Antivirals
por: Mushtaq, Saima, et al.
Publicado: (2022)

Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection
por: Wang, Gary P., et al.
Publicado: (2018)

TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype
por: Sagnelli, Caterina, et al.
Publicado: (2016)

Fibrosis progression in paired liver biopsies from HIV/HCV co-infected patients
por: Schiavini, Monica, et al.
Publicado: (2011)

The performance of HCV GT plus RUO reagent in determining Hepatitis C virus genotypes in Taiwan
por: Huang, Ying-Chou, et al.
Publicado: (2021)

A41 Characterization of NS5 coding region resistance associated substitutions from DAA-naïve GT1 HCV-infected patients in a Portuguese cohort
por: Brandao, R, et al.
Publicado: (2018)

Whole-genome characterization and resistance-associated substitutions in a new HCV genotype 1 subtype
por: von Massow, Georg, et al.
Publicado: (2019)

Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?
por: Shanyinde, Milensu, et al.
Publicado: (2019)

Can Natural Polyphenols Help in Reducing Cytokine Storm in COVID-19 Patients?
por: Giovinazzo, Giovanna, et al.
Publicado: (2020)

Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients
por: Sagnelli, Caterina, et al.
Publicado: (2013)

Homologous recombination occurs frequently at innate GT microsatellites in normal somatic and germ cells in vivo
por: Zheng, Jianbo, et al.
Publicado: (2018)

The cobas(®) HCV GT is a new tool that accurately identifies Hepatitis C virus genotypes for clinical practice
por: Fernández-Caballero, J. A., et al.
Publicado: (2017)

Novel 6-Aminoquinazolinone Derivatives as Potential Cross GT1-4 HCV NS5B Inhibitors
por: Nasr, Tamer, et al.
Publicado: (2022)

Age-dependent development of liver fibrosis in Glmp(gt/gt) mice
por: Nesset, Cecilie K., et al.
Publicado: (2016)

Naturally Occurring Resistance Associated Substitutions in Non-Cirrhotic, Treatment Naive HCV–HIV Co-Infected Patients Does Not Affect the Treatment Response for Anti-HCV Antiviral Therapy
por: Gupta, Ekta, et al.
Publicado: (2021)

Search for the Higgs boson in the H ->WW->lvlv channel in ATLAS
por: Armbruster, A
Publicado: (2011)

Geographic distribution of HCV genotypes in Libya and analysis of risk factors involved in their transmission
por: Daw, Mohamed A, et al.
Publicado: (2015)

New patterns of HCV subtypes distribution in the Khyber Pakhtunkhwa province of Pakistan
por: Gul, Amina, et al.
Publicado: (2015)

Substituted imidazopyridines as potent inhibitors of HCV replication()
por: Vliegen, Inge, et al.
Publicado: (2009)

H->tau tau and H->tau nu with the ATLAS Detector at the LHC
por: Goncalo, R
Publicado: (2011)

Study of H(SUSY) -> Tautau -> l + Tau Jet + Etmis in CMS
por: Kinnunen, Ritva, et al.
Publicado: (1997)

Solar origin of Major GMSs with (-50nT>Dst>-100nT)
por: Kaur, S
Publicado: (2005)

Net widens for funding of <i>arXiv</i>
Publicado: (2010)

Search for the SM Higgs Boson in H->WW->lnu lnu with ATLAS
por: Schmidt, E
Publicado: (2012)

Virological and Serological Discordant Profiles in COVID-19 Pneumonia: Two Atypical Clinical Cases
por: Ranzenigo, Martina, et al.
Publicado: (2020)

Geographic differences in the epidemiological features of HCV infection in Korea
por: Kim, Kyung-Ah, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ctdjtnlc41sqj93pcu1bmckk27